Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206248184> ?p ?o ?g. }
- W4206248184 endingPage "486" @default.
- W4206248184 startingPage "479" @default.
- W4206248184 abstract "Inhibitors of the sodium-glucose cotransporter type 2 (SGLT2i) are a modern class of antihyperglycemic drugs with an insulin-independent mechanism of action. Due to its ability to effectively lower blood glucose levels, improve a number of other cardiometabolic parameters (body weight, blood pressure, uric acid), as well as reduce cardiovascular and renal risks, SGLT2i have become drugs of choice for many of patients with type 2 diabetes mellitus (T2DM). Meanwhile, along with the generally recognized classes-effects of this group of drugs, there are intragroup features, including those associated with their different selectivity in sodium-glucose cotransporters of types 1 and 2 (SGLT1 and SGLT 2). For example, one of the most studied SGLT2i, canagliflozin, in addition to its inhibitory activity against SGLT2, can also moderately block SGLT1 in the intestine and kidneys that could give a maximum efficiency in the control glycemia and others cardiometabolic parameters. In addition, canagliflozin improves not only cardiovascular, but also renal prognosis in patients with T2DM, which is reflected in the corresponding indications in the summary of product characteristics of the drug. This document summarize the established and new data regarding the efficacy and safety of canagliflozin, as well as its place in the treatment of T2DM." @default.
- W4206248184 created "2022-01-26" @default.
- W4206248184 creator A5001973905 @default.
- W4206248184 creator A5004620126 @default.
- W4206248184 creator A5012152190 @default.
- W4206248184 creator A5019124562 @default.
- W4206248184 creator A5027612655 @default.
- W4206248184 creator A5035585082 @default.
- W4206248184 creator A5035859311 @default.
- W4206248184 creator A5040976739 @default.
- W4206248184 creator A5043877274 @default.
- W4206248184 creator A5046152599 @default.
- W4206248184 creator A5049701457 @default.
- W4206248184 creator A5053072984 @default.
- W4206248184 creator A5055181412 @default.
- W4206248184 creator A5072572369 @default.
- W4206248184 creator A5072924561 @default.
- W4206248184 creator A5079821394 @default.
- W4206248184 creator A5080714715 @default.
- W4206248184 creator A5081957036 @default.
- W4206248184 date "2022-01-04" @default.
- W4206248184 modified "2023-10-01" @default.
- W4206248184 title "Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board" @default.
- W4206248184 cites W1555860740 @default.
- W4206248184 cites W1996837305 @default.
- W4206248184 cites W2007299070 @default.
- W4206248184 cites W2044773944 @default.
- W4206248184 cites W2047553605 @default.
- W4206248184 cites W2052526874 @default.
- W4206248184 cites W2056976690 @default.
- W4206248184 cites W2059600600 @default.
- W4206248184 cites W2068171948 @default.
- W4206248184 cites W2129512027 @default.
- W4206248184 cites W2130570549 @default.
- W4206248184 cites W2131135469 @default.
- W4206248184 cites W2134932941 @default.
- W4206248184 cites W2155287847 @default.
- W4206248184 cites W2166823746 @default.
- W4206248184 cites W2168926920 @default.
- W4206248184 cites W2338046714 @default.
- W4206248184 cites W2409050228 @default.
- W4206248184 cites W2605480172 @default.
- W4206248184 cites W2764235987 @default.
- W4206248184 cites W2769721741 @default.
- W4206248184 cites W2795138301 @default.
- W4206248184 cites W2809013813 @default.
- W4206248184 cites W2810458929 @default.
- W4206248184 cites W2898735507 @default.
- W4206248184 cites W2899764361 @default.
- W4206248184 cites W2901946789 @default.
- W4206248184 cites W2921723272 @default.
- W4206248184 cites W2939222610 @default.
- W4206248184 cites W2969703976 @default.
- W4206248184 cites W2990953039 @default.
- W4206248184 cites W2995731459 @default.
- W4206248184 cites W3005627128 @default.
- W4206248184 cites W3008828026 @default.
- W4206248184 cites W3043378534 @default.
- W4206248184 cites W3073811870 @default.
- W4206248184 cites W3086985336 @default.
- W4206248184 cites W3089283105 @default.
- W4206248184 cites W3117247115 @default.
- W4206248184 cites W4254445254 @default.
- W4206248184 doi "https://doi.org/10.14341/dm12848" @default.
- W4206248184 hasPublicationYear "2022" @default.
- W4206248184 type Work @default.
- W4206248184 citedByCount "2" @default.
- W4206248184 countsByYear W42062481842022 @default.
- W4206248184 countsByYear W42062481842023 @default.
- W4206248184 crossrefType "journal-article" @default.
- W4206248184 hasAuthorship W4206248184A5001973905 @default.
- W4206248184 hasAuthorship W4206248184A5004620126 @default.
- W4206248184 hasAuthorship W4206248184A5012152190 @default.
- W4206248184 hasAuthorship W4206248184A5019124562 @default.
- W4206248184 hasAuthorship W4206248184A5027612655 @default.
- W4206248184 hasAuthorship W4206248184A5035585082 @default.
- W4206248184 hasAuthorship W4206248184A5035859311 @default.
- W4206248184 hasAuthorship W4206248184A5040976739 @default.
- W4206248184 hasAuthorship W4206248184A5043877274 @default.
- W4206248184 hasAuthorship W4206248184A5046152599 @default.
- W4206248184 hasAuthorship W4206248184A5049701457 @default.
- W4206248184 hasAuthorship W4206248184A5053072984 @default.
- W4206248184 hasAuthorship W4206248184A5055181412 @default.
- W4206248184 hasAuthorship W4206248184A5072572369 @default.
- W4206248184 hasAuthorship W4206248184A5072924561 @default.
- W4206248184 hasAuthorship W4206248184A5079821394 @default.
- W4206248184 hasAuthorship W4206248184A5080714715 @default.
- W4206248184 hasAuthorship W4206248184A5081957036 @default.
- W4206248184 hasBestOaLocation W42062481841 @default.
- W4206248184 hasConcept C126322002 @default.
- W4206248184 hasConcept C134018914 @default.
- W4206248184 hasConcept C2775887513 @default.
- W4206248184 hasConcept C2777180221 @default.
- W4206248184 hasConcept C2777422806 @default.
- W4206248184 hasConcept C2777451236 @default.
- W4206248184 hasConcept C2779881121 @default.
- W4206248184 hasConcept C2780473172 @default.
- W4206248184 hasConcept C2910068830 @default.